Synovus Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,699
| Closed | -$459K | – | 925 |
|
|
2025
Q1 | $459K | Sell |
3,699
-15,507
| -81% | -$1.93M | 0.01% | 677 |
|
|
2024
Q4 | $2.37M | Buy |
19,206
+100
| +0.5% | +$12.3K | 0.03% | 319 |
|
|
2024
Q3 | $2.13M | Buy |
19,106
+451
| +2% | +$50.2K | 0.02% | 365 |
|
|
2024
Q2 | $1.99M | Buy |
18,655
+91
| +0.5% | +$9.71K | 0.03% | 341 |
|
|
2024
Q1 | $2.24M | Buy |
18,564
+239
| +1% | +$28.8K | 0.03% | 321 |
|
|
2023
Q4 | $2.25M | Buy |
18,325
+108
| +0.6% | +$13.3K | 0.03% | 302 |
|
|
2023
Q3 | $2.36M | Buy |
+18,217
| New | +$2.36M | 0.03% | 315 |
|
|
2020
Q3 | – | Sell |
-3,208
| Closed | -$354K | – | 1076 |
|
|
2020
Q2 | $354K | Sell |
3,208
-168
| -5% | -$18.5K | 0.01% | 539 |
|
|
2020
Q1 | $328K | Buy |
3,376
+451
| +15% | +$43.8K | ﹤0.01% | 644 |
|
|
2019
Q4 | $435K | Buy |
2,925
+164
| +6% | +$24.4K | 0.01% | 504 |
|
|
2019
Q3 | $363K | Buy |
2,761
+106
| +4% | +$13.9K | 0.01% | 537 |
|
|
2019
Q2 | $384K | Buy |
2,655
+2,351
| +773% | +$340K | 0.01% | 506 |
|
|
2019
Q1 | $44K | Hold |
304
| – | – | ﹤0.01% | 843 |
|
|
2018
Q4 | $38K | Hold |
304
| – | – | ﹤0.01% | 848 |
|
|
2018
Q3 | $51K | Buy |
+304
| New | +$51K | ﹤0.01% | 837 |
|